Single‐center study to determine the safety and efficacy of CT‐707 in Chinese patients with advanced anaplastic lymphoma kinase‐rearranged non‐small‐cell lung cancer

INTRODUCTION: It has been proven that ALK‐rearranged non‐small cell lung cancer (NSCLC) is sensitive to ALK inhibitors while the chemotherapy resistance is unavoidable. In this study, safety and antitumor activity of the novel ALK inhibitor (ALKi) CT‐707 were evaluated in Chinese patients with advan...

Full description

Saved in:
Bibliographic Details
Published in:Thorac Cancer
Main Authors: Song, Peng, Zhang, Xiaotong, Yang, Dongliang, Wang, Hanping, Si, Xiaoyan, Zhang, Li
Format: Artigo
Language:Inglês
Published: John Wiley & Sons Australia, Ltd 2020
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7180692/
https://ncbi.nlm.nih.gov/pubmed/32181989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13376
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items